PHX: Shoulder Prosthesis, Reverse Configuration
What it covers
Intended to be used to relieve pain and to replace the glenoid and humeral side of the shoulder joint in order to restore mobility in a grossly rotator cuff deficient joint with severe arthropathy or a previous joint replacement with a grossly rotator cuff deficient joint.
FDA’s definition of product code PHX, from the Product Classification database.
FDA flags PHX devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K263086 | AltiVate Reverse® Glenosphere with RAVN Technology | Encore Medical L.P. | Oct 2, 2026 | Special |
| K260556 | Veritas Shoulder System | Restor3D | Jul 1, 2026 | Traditional |
| K261683 | Augment Off-Axis Instrument System | Zimmer, Inc. | Jun 16, 2026 | Special |
| K260102 | Tornier Perform Reversed Glenoid and Tornier Perform Reversed Augmented Glenoid Shoulder System | Stryker Corporation (Tornier, Inc.) | Jun 12, 2026 | Traditional |
| K261016 | MSS - Humeral reverse liners extension | Medacta International, SA | Jun 10, 2026 | Traditional |
| K253992 | Veritas Reverse Total Shoulder System | Restor3D | May 7, 2026 | Traditional |
| K252404 | Comprehensive Reverse Shoulder - HA Glenosphere Baseplates | Biomet Orthopedics | Apr 15, 2026 | Traditional |
| K260583 | Equinoxe® Shoulder System | Exactech, Inc. | Apr 14, 2026 | Traditional |
| K254128 | InSet Reverse Total Shoulder System | Shoulder Innovations, Inc. | Apr 13, 2026 | Traditional |
| K253674 | Blueprint Patient-Specific Instrumentation | Stryker Corporation (Tornier, S.A.S.) | Apr 3, 2026 | Traditional |
Clearances by year
173 PHX 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 17 | 132 |
| 2025 | 9 | 72 |
| 2024 | 9 | 139 |
| 2023 | 9 | 154 |
| 2022 | 9 | 198 |
| 2021 | 21 | 143 |
| 2020 | 13 | 143 |
| 2019 | 9 | 144 |
| 2018 | 14 | 127 |
| 2017 | 11 | 141 |
| 2016 | 4 | 132 |
| 2015 | 4 | 206 |
| 2014 | 12 | 110 |
| 2013 | 8 | 143 |
| 2012 | 12 | 114 |
| 2011 | 12 | 94 |
Who submits
39 applicants cleared a PHX device since 2011. 65% of the clearances went to applicants in United States, then France (13%), Switzerland (9%) and Ireland (6%). By type: Traditional 78% and Special 22%.
| Applicant | Clearances since 2011 |
|---|---|
| Encore Medical L.P. | 14 |
| Exactech, Inc. | 14 |
| Medacta International S.A. | 12 |
| Arthrex, Inc. | 11 |
| Biomet Manufacturing Corp | 11 |
| Lima Corporate S.P.A. | 11 |
| Tornier, Inc. | 10 |
| Fx Shoulder USA, Inc. | 9 |
How FDA classifies it
Class II. The special controls for this device are:
(1) FDA's:
(i) “Use of International Standard ISO 10993 ‘Biological Evaluation of Medical Devices—Part I: Evaluation and Testing,’ ”
(ii) “510(k) Sterility Review Guidance of 2/12/90 (K90-1),”
(iii) “Guidance Document for Testing Orthopedic Implants with Modified Metallic Surfaces Apposing Bone or Bone Cement,”
(iv) “Guidance Document for the Preparation of Premarket Notification (510(k)) Application for Orthopedic Devices,” and
(v) “Guidance Document for Testing Non-articulating, ‘Mechanically Locked’ Modular Implant Components,”
(2) International Organization for Standardization's (ISO):
(i) ISO 5832-3:1996 “Implants for Surgery—Metallic Materials—Part 3: Wrought Titanium 6-aluminum 4-vandium Alloy,”
(ii) ISO 5832-4:1996 “Implants for Surgery—Metallic Materials—Part 4: Cobalt-chromium-molybdenum casting alloy,”
(iii) ISO 5832-12:1996 “Implants for Surgery—Metallic Materials—Part 12: Wrought Cobalt-chromium-molybdenum alloy,”
(iv) ISO 5833:1992 “Implants for Surgery—Acrylic Resin Cements,”
(v) ISO 5834-2:1998 “Implants for Surgery—Ultra-high Molecular Weight Polyethylene—Part 2: Moulded Forms,”
(vi) ISO 6018:1987 “Orthopaedic Implants—General Requirements for Marking, Packaging, and Labeling,” and
(vii) ISO 9001:1994 “Quality Systems—Model for Quality Assurance in Design/Development, Production, Installation, and Servicing,” and
(3) American Society for Testing and Materials':
(i) F 75-92 “Specification for Cast Cobalt-28 Chromium-6 Molybdenum Alloy for Surgical Implant Material,”
(ii) F 648-98 “Specification for Ultra-High-Molecular-Weight Polyethylene Powder and Fabricated Form for Surgical Implants,”
(iii) F 799-96 “Specification for Cobalt-28 Chromium-6 Molybdenum Alloy Forgings for Surgical Implants,”
(iv) F 1044-95 “Test Method for Shear Testing of Porous Metal Coatings,”
(v) F 1108-97 “Specification for Titanium-6 Aluminum-4 Vanadium Alloy Castings for Surgical Implants,”
(vi) F 1147-95 “Test Method for Tension Testing of Porous Metal,”
(vii) F 1378-97 “Standard Specification for Shoulder Prosthesis,” and
(viii) F 1537-94 “Specification for Wrought Cobalt-28 Chromium-6 Molybdenum Alloy for Surgical Implants.”
From 21 CFR 888.3660. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 888.3660 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent PHX clearances declared.
Ask about PHX
Questions about PHX
What is FDA product code PHX?
Product code PHX, “Shoulder Prosthesis, Reverse Configuration” in FDA's classification database, is a Class II device type under 21 CFR 888.3660 (shoulder joint metal/polymer semi-constrained cemented prosthesis), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 206 clearances under PHX, 173 of them since 2011.
How many 510(k) clearances are there under PHX?
FDA’s 510(k) database listed 206 clearances under PHX as of Oct 29, 2026, 173 of them decided since 2011; the most recent decision was Oct 2, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a PHX 510(k)?
For the 27 PHX clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 128 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most PHX clearances?
Since 2011: Encore Medical L.P. (14), Exactech, Inc. (14), Medacta International S.A. (12), Arthrex, Inc. (11) and Biomet Manufacturing Corp (11). 39 applicants have cleared a PHX device in that time.